Micro- and small-cap firms saw significant gains last week, with BioXcel Therapeutics, Inc. standing out with a 56% increase in share price due to positive news on its BXCL501 study.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week
